FDA to Give Companies Advance Notice of Generic RTRs, CRLs and Approvals

Drug Industry Daily
A A
The FDA is streamlining its communications with generics manufacturers, and outlined its procedures for relaying the status of an ANDA review in a new manual for staff.

To View This Article:

Login

Subscribe To Drug Industry Daily